|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.330 EGP | -2.21% |
|
+6.40% | +16.67% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-20 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 1.36 | 1.53 | 1.96 |
| Spread/Res. | -2.21% | -13.07% | -32.14% |
| Spread/Supp. | +4.72% | +25.47% | +27.64% |
| Support | 1.27 | 1.06 | 1.042 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MCRO Stock
- Charts Macro Group Pharmaceuticals (Macro Capital) S.A.E
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
